Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antifungal susceptibility testing with YeastONE™ is not predictive of clinical outcomes of Cryptococcus neoformans var. grubii fungemia.

Medical mycology - 3 Nov 2021

Yang Jeng-How, Huang Po-Yen, Cheng Chun-Wen, Shie Shian-Sen, Lin Zhong-Fu, Yang Lan-Yan, Lee Chia-Hui, Wu Ting-Shu

Abstract excerpt

Mortality rates due to Cryptococcus neoformans var. grubii fungemia remain significant despite treatment with antifungal drugs. The predictive function of antifungal susceptibility and its correlation with treatment outcome remains controversial. A retrospective study was conducted from January 1, 2009, to December 31, 2016, on 85 patients with C. neoformans var. grubii fungemia confirmed by matrix-assisted laser...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antifungal Agents
Share to China

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cryptococcosis

Share to Cryptococcus neoformans

Share to Disease Susceptibility

Share to Drug Resistance, Fungal

Share to Microbial Sensitivity Tests

Share to Serogroup

Source

Identifiers

PMID: 34374784
DOI: 10.1093/mmy/myab046

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antifungal susceptibility testing with YeastONE™ is not predictive of clinical outcomes of Cryptococcus neoformans var. grubii fungemia.PMID 34374784Read ↗

The emerging fungal pathogen Cryptococcus gattii: Epidemiology, pathogenesis, immunomodulatory attributes, and drug susceptibilitySemantic proximity Read ↗

The Cryptococcus gattii species complex: Unique pathogenic yeasts with understudied virulence mechanismsSemantic proximity Read ↗

Microbiological, Epidemiological, and Clinical Characteristics of Patients With Cryptococcal Meningitis at a Tertiary Hospital in China: A 6-Year Retrospective AnalysisSemantic proximity Read ↗

Fusarium and Neocosmospora : fungal priority pathogens in laboratory diagnosisSemantic proximity Read ↗

Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.Semantic proximity Read ↗

Antifungal susceptibility and molecular characteristics of Cryptococcus spp. based on whole-genome sequencing in Zhejiang Province, ChinaSemantic proximity Read ↗

Recognition of seven species in the Cryptococcus gattii/Cryptococcus neoformans species complex.Semantic proximity Read ↗

Comparison of Cryptococcus gattii/neoformans Species Complex to Related Genera (Papiliotrema and Naganishia) Reveal Variances in Virulence Associated Factors and Antifungal SusceptibilitySemantic proximity Read ↗

Rapid Identification of Cryptococcus neoformans var. grubii, C. neoformans var. neoformans, and C. gattii by Use of Rapid Biochemical Tests, Differential Media, and DNA SequencingSemantic proximity Read ↗

Antifungal susceptibilities of Cryptococcus species complex isolates from AIDS and non-AIDS patients in Southeast China.Semantic proximity Read ↗

Cryptococcus gattii InfectionsSemantic proximity Read ↗

Early diagnosis of Cryptococcus neoformans var. grubii meningitis using multiplex PCR assay in an immunocompetent patient.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.